369
Views
52
CrossRef citations to date
0
Altmetric
Review

Impact of long-term use of opioids on quality of life in patients with chronic, non-malignant pain

, &
Pages 1555-1568 | Accepted 05 Aug 2005, Published online: 01 Sep 2005

References

  • Elliott AM, Smith BH, Penny KI, et al. The epidemiology of chronic pain in the community. Lancet 1999;354:1248–52
  • Elliott AM, Smith BH, Hannaford PC, et al. The course of chronic pain in the community: results of a 4-year follow-up study. Pain 2002;99:299–307
  • Latham J, Davis BD. The socioeconomic impact of chronic pain. Disabil Rehabil 1994;16:39–44
  • Clark JD. Chronic pain prevalence and analgesic prescribing in a general medical population. J Pain Symptom Manage 2002;23:131–7
  • Schmier JK, Palmer CS, Flood EM, et al. Utility assessments of opioid treatment for chronic pain. Pain Med 2002;3:218–30
  • Ballantyne JC. Chronic pain following treatment for cancer: the role of opioids. Oncologist 2003;8:567–75
  • Cancer Pain Relief and Palliative Care. Geneva, Switzerland: World Health Organization, Technical Report Series No 804, 1990
  • Slavin KV, Tesoro EP, Mucksavage JJ. The treatment of cancer pain. Drugs Today (Barc) 2004;40:235–45
  • Haythornthwaite JA, Menefee LA, Quatrano-Piacentini AL, et al. Outcome of chronic opioid therapy for non-cancer pain. J Pain Symptom Manage 1998;15:185–94
  • Pappagallo M, Heinberg LJ. Ethical issues in the management of chronic nonmalignant pain. Semin Neurol 1997;17:203–11
  • Turk DC, Brody MC, Okifuji EA. Physicians' attitudes and practices regarding the long-term prescribing of opioids for noncancer pain. Pain 1994;59:201–8
  • Portenoy RK. Opioid therapy for chronic nonmalignant pain: a review of the critical issues. J Pain Symptom Manage 1996;11:203–17
  • Cherny NI. Opioid analgesics: comparative features and prescribing guidelines. Drugs 1996;51:713–37
  • Arkinstall W, Sandler A, Goughnour B, et al. Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial. Pain 1995; 62:169–78
  • Jamison RN, Raymond SA, Slawsby EA, et al. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine 1998;23:2591–600
  • Moulin DE, Iezzi A, Amireh R, et al. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143–7
  • The use of opioids for the treatment of chronic pain. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997;13:6–8
  • The management of chronic pain in older persons. AGS Panel on Chronic Pain in Older Persons. American Geriatric Society. Geriatrics 1998;53:S8–24
  • Recommendations for the appropriate use of opioids for persistent non-cancer pain. A consensus statement prepared on behalf of the Pain Society, the Royal College of Anaesthetists, the Royal College of General Practitioners and the Royal College of Psychiatrists. March 2004. Available from http://www.%20britishpainsociety.org/pdf/opioids_doc_2004.pdf [Accessed June 2005]
  • Allan L, Simpson K, Slappendel R, et al. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic lower back pain. Spine [in press]
  • Chou R, Clark E, Helfand M. Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review. J Pain Symptom Manage 2003;26:1026–48
  • Kalso E, Edwards JE, Moore RA, et al. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372–80
  • Bannwarth B. Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf 1999;21:283–96
  • McNicol E, Horowicz-Mehler N, Fisk RA, et al. Americal Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review. J Pain 2003;4: 231–56
  • Galer BS, Coyle N, Pasternak GW, et al. Individual variability in the response to different opioids: report of five cases. Pain 1992;49:87–91
  • McQuay HJ. Opioid use in chronic pain. Oxford Pain Relief Database. Available from http://www.jr2.ox.ac.uk/bandolier/%20booth/painpag/wisdom/S31.html [Accessed 21 March 2005]
  • McQuay HJ. Relief of chronic non-malignant pain. Oxford Pain Relief Database. Available from http://www.jr2.ox.ac.uk/bandolier/%20booth/painpag/wisdom/493HJM.html [Accessed 21 March 2005]
  • Jamison RN. Comprehensive pretreatment and outcome assessment for chronic opioid therapy in nonmalignant pain. J Pain Symptom Manage 1996;11:231–41
  • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996;17:1–12
  • Allan L, Hays H, Jensen NH, et al. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain. BMJ 2001;322:1154–8
  • Babul N, Noveck R, Chipman H, et al. Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee. J Pain Symptom Manage 2004;28:59–71
  • Boureau F, Legallicier P, Kabir-Ahmadi M. Tramadol in postherpetic neuralgia: a randomized, double-blind, placebocontrolled trial. Pain 2003;104:323–31
  • Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology 1998;50:1842–6
  • Moulin DE, Iezzi A, Amireh R, et al. Randomised trial of oral morphine for chronic non-cancer pain. Lancet 1996;347:143–7
  • Dellemijn PL, van Duijn H, Vanneste JA. Prolonged treatment with transdermal fentanyl in neuropathic pain. J Pain Symptom Manage 1998;16:220–9
  • Franco ML, Seoane A, Franco ML, et al. Usefulness of transdermal fentanyl in the management of nonmalignant chronic pain: A prospective, observational, multicenter study. Pain Clinic 2002;14:99–112
  • Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain 2001;2: 197–204
  • Mystakidou K, Parpa E, Tsilika E, et al. Long-term management of noncancer pain with transdermal therapeutic system-fentanyl. J Pain 2003;4:298–306
  • Tassain V, Attal N, Fletcher D, et al. Long term effects of oral sustained release morphine on neuropsychological performance in patients with chronic non-cancer pain. Pain 2003;104: 389–400
  • Jage J. Medikamente gegen Krebsschmerzen. Thieme, Stuttgart, 2002, ISBN 3-8261-0157–X
  • Brown J, Klapow J, Doleys D, et al. Disease-specific and generic health outcomes: a model for the evaluation of long-term intrathecal opioid therapy in noncancer low back pain patients. Clin J Pain 1999;15:122–31
  • Mironer YE, Tollison CD. Methadone in the intrathecal treatment of chronic nonmalignant pain resistant to other neuroaxial agents: the first experience. Neuromodulation 2001; 4:25–31
  • Savage SR. Long-term opioid therapy: assessment of consequences and risks. J Pain Symptom Manage 1996;11:274–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.